20 June 2022>: Clinical Research
A Single-Center Retrospective Study to Compare the Efficacy and Safety of Modified FOLFIRINOX with S-1 as Adjuvant Chemotherapy in 71 Patients with Resected Pancreatic Carcinoma
Linhua Yao 1ABCEF , Chengwu Tang 2ABCEF , Wenming Feng 2ABFG , Hanbin Dai 2ABCE*DOI: 10.12659/MSM.937136
Med Sci Monit 2022; 28:e937136
Table 2 Chemotherapy-induced adverse events.
Event | mFFX group | S-1 group | P value | ||||||
---|---|---|---|---|---|---|---|---|---|
Grade | Grade | ||||||||
1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | ||
Neutropenia | 14 | 13 | 5 | 2 | 17 | 14 | 5 | 1 | 0.5976 |
Thrombocytopenia | 9 | 14 | 9 | 2 | 17 | 15 | 4 | 1 | 0.0372 |
Anemia | 18 | 10 | 1 | 0 | 19 | 10 | 1 | 0 | 0.6863 |
Fatigue | 16 | 4 | 2 | 0 | 18 | 13 | 1 | 0 | 0.0226 |
Nausea/vomiting | 9 | 18 | 6 | 0 | 13 | 17 | 2 | 0 | 0.0337 |
Diarrhea | 10 | 15 | 5 | 2 | 16 | 13 | 0 | 0 | 0.0018 |
Elevated creatinine level | 4 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0.3393 |
Elevated ALT/AST level | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0.1388 |
Elevated total serum bilirubin level | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0.2672 |
Stomatitis | 6 | 4 | 4 | 0 | 4 | 5 | 2 | 0 | 0.2156 |
Hand-foot syndrome | 1 | 1 | 0 | 0 | 4 | 2 | 2 | 0 | 0.0569 |
Paresthesia | 6 | 5 | 2 | 0 | 3 | 4 | 4 | 0 | 0.6412 |
ALT – alanine aminotransferase; AST – aspartate aminotransferase. |